The NZX50 is home to a surprising number of stocks that analysts believe are trading below what they’re worth. Data from InvestingPro shows that more than 25 NZX-listed companies currently carry a “buy” or “strong buy” rating, with some showing upside potential of over 60% against estimated fair value. For someone putting money into the New Zealand market, that gap between current price and fair value is the difference between buying a dollar’s worth of assets for 60 cents and overpaying. It’s also where the real risk sits — because fair value is an estimate, not a promise.
Disclosure: Some links on this page are affiliate links. If you make a purchase through them, Britwealth may earn a commission at no extra cost to you. We only include products and services that are relevant to the topic.
This article is general information only and does not constitute professional advice. For your specific situation, consult a qualified professional.
The research points to three stocks that keep appearing near the top of these undervaluation lists — Pacific Edge, Heartland Group, and Scales Corp. Each operates in a different sector, and each has a different story behind why it might be priced below what analysts think it’s worth. What ties them together is the size of the gap. Understanding what creates that gap, and whether it signals an opportunity or a trap, is what this article walks through.
Here’s what you actually need to know.
What Undervaluation Really Means and Three Stocks That Fit the Pattern
The term undervalued gets thrown around a lot, so it’s worth being precise about what it means in practice.
What I tend to notice is that people hear “undervalued” and think “guaranteed rise.” The research suggests the opposite — the biggest upside gaps often come with the most fragile financial health. The stocks that balance a meaningful gap with solid fundamentals tend to be the ones worth watching, not necessarily the ones with the flashiest percentage. That’s the lens worth holding during a market correction.
The Numbers That Matter Most for These Three Stocks
Each of the three stocks has a different profile when you look under the hood. A table makes the comparisons clearer than prose ever could.
→ Scroll right to see all columns
| Stock | Price (NZD) | Upside Potential | Sector | Analyst Rating | Financial Health |
|---|---|---|---|---|---|
| Pacific Edge (PEBP) | 0.54 | +61.83% | Health Technology | Strong Buy | Fair |
| Heartland Group (HGH) | 1.21 | +45.78% | Finance | Buy | Good |
| Scales Corp (SCL) | 6.61 | +37.71% | Process Industries | Buy | Great |
The upside figure is the difference between the current market price and the analyst fair value estimate, expressed as a percentage. For Pacific Edge, a 61.83% upside means that if the stock reaches the 0.87 NZD fair value estimate, a buyer at the current 0.54 NZD would see that gain on paper. But Pacific Edge also has a P/E of 16.89 with negative five-year earnings-per-share growth, which is why its financial health is rated fair rather than great.
Heartland Group shows a 45.78% upside with “good” financial health and a P/E of 13.55, which puts it in a more conventional value range. Its five-year EPS growth is positive at 0.09 NZD, suggesting the business is growing earnings rather than shrinking into its valuation gap. Scales Corp, with a 37.71% upside and “great” financial health, has the strongest underlying business quality of the three. Its P/E of 9.42 is below the NZX50 average, and it has posted five-year EPS growth of 2.25 NZD — the strongest earnings trajectory of the group.
The pattern is clear: the largest gap doesn’t align with the strongest business. Scales Corp has the smallest upside of the three but the cleanest fundamentals. That trade-off is the core decision anyone looking at these stocks needs to weigh.
Where Most Investors Go Wrong With Undervalued Stock Picks
Treating a Low Share Price as a Signal of Value
A stock at 0.54 NZD can look cheap, but price per share is a function of how many shares exist, not how cheap the company is. Pacific Edge’s market cap is roughly 59 million NZD. A low share price doesn’t mean it’s undervalued — it means the company is small and the market has priced its earnings prospects accordingly. What matters is whether the earnings and assets support the current price, not whether the price looks small in absolute terms.
Ignoring Financial Health Ratings When Chasing Upside
Pacific Edge carries a “fair” financial health rating with a negative five-year EPS growth trend of -0.04 NZD. A stock can be undervalued because the market correctly sees deteriorating fundamentals that the fair value estimate hasn’t adjusted for. In that case, the gap closes not by the price rising but by the fair value estimate dropping toward the price. The fix is straightforward: check the financial health rating and earnings trend before looking at the upside percentage. The basics of stock research start with cash flow, not price.
Assuming Analyst Ratings Are Current
The “strong buy” and “buy” ratings in the research reflect analyst consensus at a specific point in time. Ratings can lag by weeks or months. If a company releases weak earnings after the rating was issued, the fair value estimate may no longer hold. Checking the date of the latest analyst report before acting on a rating prevents buying into stale information. Most brokers and financial data platforms show the date of the last analyst update.
Overlooking Dividend Sustainability
Heartland Group yields around 5.35%, which looks attractive on the surface. But a dividend yield that high in a stock with a P/E of 13.55 can signal that the market expects the dividend to be cut. The financial health rating being “good” rather than “great” reinforces the point — check the payout ratio (dividends divided by earnings) to see whether the company can afford to keep paying at that rate. A payout ratio over 80% is a warning sign, regardless of how undervalued the stock appears.
How to Evaluate Undervalued NZ Stocks Step by Step
Start With the Financial Health Rating, Not the Upside
The research uses a four-tier financial health scale: great, good, fair, and weak. Scales Corp scores “great” with a P/E of 9.42 and five-year EPS growth of 2.25 NZD. That combination — strong earnings growth and a below-market P/E — is the closest thing to a conventional value stock in this group. My first move would be to filter any undervaluation screen by financial health first, then look at upside. The stocks that survive both filters are the ones worth investigating further.
Compare the P/E Ratio to the Sector Average
A P/E of 9.42 for Scales Corp needs context. If the NZX agriculture or process industries sector average P/E is around 14–15, then 9.42 represents a genuine discount. But if the sector average is also around 9–10, the stock is fairly valued relative to its peers and the “undervaluation” may simply reflect a low-margin industry. Sector-relative comparison prevents confusing a cheap industry for a cheap stock. You can find sector average P/E data on most brokerage platforms or financial data sites.
Check the Earnings Trend, Not Just the Latest Figure
Pacific Edge has negative five-year EPS growth of -0.04 NZD. A stock with declining earnings can appear undervalued on a trailing P/E basis while the fair value estimate collapses as future earnings are revised down. The earnings trajectory over 3–5 years tells you whether the business is growing into its valuation or shrinking away from it. Positive EPS growth over five years, like Scales Corp’s 2.25 NZD or Heartland Group’s 0.09 NZD, supports the case that the undervaluation is temporary rather than structural. Where you need a deeper dive into a company’s financial statements, specialist financial research support can help clarify the metrics.
Upcoming Rule Changes That Affect NZX Valuations
The New Zealand government has signalled potential changes to foreign investment rules and disclosure requirements for listed companies. Tighter disclosure rules typically increase transparency, which can lead to fair value estimates adjusting — either up or down — as previously opaque information becomes public. Any investor holding undervalued stocks when these changes take effect should expect fair value estimates to shift. This is not a reason to avoid the stocks, but it is a reason to check that the margin of safety (the gap between price and fair value) is wide enough to absorb a 10–15% fair value adjustment without turning into a loss.
Frequently Asked Questions About Undervalued NZ Stocks
What P/E ratio counts as undervalued on the NZX? ▾
Can a stock with negative earnings be undervalued? ▾
How often do fair value estimates update? ▾
What is a “strong buy” vs a “buy” rating? ▾
What happens if fair value drops after I buy? ▾
Why the Size of the Gap Matters Less Than What Created It
The three stocks here — Pacific Edge, Heartland Group, and Scales Corp — each show a genuine fair value gap, but the stories behind those gaps are different. Scales Corp’s gap comes from a strong business trading below its sector average P/E with solid earnings growth. Pacific Edge’s gap comes from a high-risk health technology company with weak earnings trends that analysts still believe in. Those are two different investment propositions dressed in the same “undervalued” label. The difference determines whether the gap closes in your favour or against it.
Remember: this article is general information only. For advice on your specific situation, speak to a qualified professional.
If this was useful, you might also want to read Property vs Shares: The Ultimate Investment Showdown for Kiwis.
Sources and Further Reading
10 Essential Tips for Building a Diversified Stock Portfolio in New Zealand — Practical guidance for spreading NZX risk across sectors and company sizes.
Investing.com (2024). Most Undervalued Stocks — New Zealand. 🔗
Money Balance (2024). Best NZX Stocks — Strategies for Investing. 🔗
TradingView (2024). New Zealand Stocks — Best Yearly Performance. 🔗
